immune globulin intravenous (human) - ifas 10 % per 25 ML Injection

RxCUI
2102455
RxNorm name
immune globulin intravenous (human) - ifas 10 % per 25 ML Injection
Display name
immune globulin intravenous (human) - ifas 10 % per 25 ML Injection
Full name
immune globulin intravenous (human) - ifas 10 % per 25 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125587PanzygaImmune Globulin Intravenous (Human)-ifas351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PanzygaIMMUNE GLOBULIN INTRAVENOUS (HUMAN)Octapharma USA Inc9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e02025-05-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2102455
PanzygaIMMUNE GLOBULIN INTRAVENOUS (HUMAN)Pfizer Laboratories Div Pfizer Ince2cc5ddf-119e-ade3-79c2-c712cfbee0992025-05-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2102455

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68a5ee5f-0352-b3ae-3321-c0a22947a31dimmune globulin intravenous (human) - ifas 10 % in 25 ML Injection [PSN] · 25 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [SCD] · immune globulin intravenous (human) - ifas 10 % per 25 ML Injection [SY]311These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820210215
e2cc5ddf-119e-ade3-79c2-c712cfbee099immune globulin intravenous (human) - ifas 10 % in 25 ML Injection [PSN] · 25 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [SCD] · immune globulin intravenous (human) - ifas 10 % per 25 ML Injection [SY]310These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0immune globulin intravenous (human) - ifas 10 % in 25 ML Injection [PSN] · 25 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [SCD] · immune globulin intravenous (human) - ifas 10 % per 25 ML Injection [SY]32These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508